Wray backs TranXenoGen

Nigel Wray has been identified as a key backer of TranXenoGen, the biotech firm.

TranXenoGen is joining the Alternative Investment Market latter this month, capitalised at £60m.

Wray has made his name in property development as chairman of Burford Holdings